PhasiQ Awarded NSF Grant to Develop Multiplex Protein Biomarker Test for DVT

1024 260 Arlyne Simon, PhD | Biochemical Engineer. Author. Inventor. Entrepreneur.

Immunoassay developer PhasiQ this week received a two-year grant from the National Science Foundation to develop and commercialize an ELISA-based multiplex protein biomarker test for identifying patients with deep vein…

This article was originally published at